Symbol
TScan Therapeutics, Inc.
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$1.84
Current price of the stock
$407K
Trading volume of the stock
$218.4M
Market capitalization of the company
Micro Cap
Category of market capitalization
-
Long-term growth mean estimate
4.67
Mean analyst rating
365.82%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
0.13
Total debt to total equity ratio
9.56
Current ratio
100.00%
Gross profit margin
-3109.82%
Operating profit margin
-3109.82%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-2849.09%
Pretax profit margin
-2849.09%
Net profit margin
-13.05%
Measures profitability relative to shareholders' equity
-13.05%
ROE excluding intangible assets
-8.59%
Measures profitability relative to total assets
-11.51%
Measures profitability relative to invested capital
0.00
Asset turnover ratio
-
Inventory turnover ratio
-
Receivables turnover ratio
-
Average number of days it takes to collect receivables
-3.47
Measures valuation relative to earnings
-
P/E based on future earnings estimates
23.33
Measures valuation relative to sales
0.43
Measures valuation relative to book value
-0.76
Measures valuation relative to operating cash flow
-0.73
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
